Click for best price
Implantable NeedleFree Drug Delivery Market Size, Share 2022
Implantable drug delivery system becomes new kind of drug delivery system which can directly implant in the human body to optimize therapeutic properties. The needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases.
This report contains market size and forecasts of Implantable and Needle-Free Drug Delivery in Global, including the following market information:
Global Implantable and Needle-Free Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Implantable and Needle-Free Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Implantable Drug Delivery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Implantable and Needle-Free Drug Delivery include Boston Scientific, Bayer, Medtronic, Pharmajet, Crossject, BD and Mystic Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Implantable and Needle-Free Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Implantable and Needle-Free Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Implantable and Needle-Free Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Implantable Drug Delivery
Needle-Free Drug Delivery
Global Implantable and Needle-Free Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Implantable and Needle-Free Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Implantable and Needle-Free Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Implantable and Needle-Free Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Implantable and Needle-Free Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Implantable and Needle-Free Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific
Bayer
Medtronic
Pharmajet
Crossject
BD
Mystic Pharmaceuticals
| Report Attributes |
Report Details |
| Report Title |
Implantable and Needle-Free Drug Delivery Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Implantable and Needle-Free Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Implantable and Needle-Free Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Implantable and Needle-Free Drug Delivery Overall Market Size
2.1 Global Implantable and Needle-Free Drug Delivery Market Size: 2021 VS 2028
2.2 Global Implantable and Needle-Free Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Implantable and Needle-Free Drug Delivery Players in Global Market
3.2 Top Global Implantable and Needle-Free Drug Delivery Companies Ranked by Revenue
3.3 Global Implantable and Needle-Free Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Implantable and Needle-Free Drug Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Implantable and Needle-Free Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Implantable and Needle-Free Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Implantable and Needle-Free Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Implantable and Needle-Free Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Implantable and Needle-Free Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Implantable Drug Delivery
4.1.3 Needle-Free Drug Delivery
4.2 By Type - Global Implantable and Needle-Free Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Implantable and Needle-Free Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global Implantable and Needle-Free Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Implantable and Needle-Free Drug Delivery Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Implantable and Needle-Free Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Implantable and Needle-Free Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global Implantable and Needle-Free Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Implantable and Needle-Free Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Implantable and Needle-Free Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Implantable and Needle-Free Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global Implantable and Needle-Free Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Implantable and Needle-Free Drug Delivery Revenue, 2017-2028
6.3.2 US Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.3.3 Canada Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.3.4 Mexico Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Implantable and Needle-Free Drug Delivery Revenue, 2017-2028
6.4.2 Germany Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.4.3 France Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.4.4 U.K. Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.4.5 Italy Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.4.6 Russia Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.4.7 Nordic Countries Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.4.8 Benelux Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Implantable and Needle-Free Drug Delivery Revenue, 2017-2028
6.5.2 China Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.5.3 Japan Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.5.4 South Korea Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.5.5 Southeast Asia Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.5.6 India Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Implantable and Needle-Free Drug Delivery Revenue, 2017-2028
6.6.2 Brazil Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.6.3 Argentina Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Implantable and Needle-Free Drug Delivery Revenue, 2017-2028
6.7.2 Turkey Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.7.3 Israel Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.7.4 Saudi Arabia Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
6.7.5 UAE Implantable and Needle-Free Drug Delivery Market Size, 2017-2028
7 Players Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Corporate Summary
7.1.2 Boston Scientific Business Overview
7.1.3 Boston Scientific Implantable and Needle-Free Drug Delivery Major Product Offerings
7.1.4 Boston Scientific Implantable and Needle-Free Drug Delivery Revenue in Global Market (2017-2022)
7.1.5 Boston Scientific Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Implantable and Needle-Free Drug Delivery Major Product Offerings
7.2.4 Bayer Implantable and Needle-Free Drug Delivery Revenue in Global Market (2017-2022)
7.2.5 Bayer Key News
7.3 Medtronic
7.3.1 Medtronic Corporate Summary
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Implantable and Needle-Free Drug Delivery Major Product Offerings
7.3.4 Medtronic Implantable and Needle-Free Drug Delivery Revenue in Global Market (2017-2022)
7.3.5 Medtronic Key News
7.4 Pharmajet
7.4.1 Pharmajet Corporate Summary
7.4.2 Pharmajet Business Overview
7.4.3 Pharmajet Implantable and Needle-Free Drug Delivery Major Product Offerings
7.4.4 Pharmajet Implantable and Needle-Free Drug Delivery Revenue in Global Market (2017-2022)
7.4.5 Pharmajet Key News
7.5 Crossject
7.5.1 Crossject Corporate Summary
7.5.2 Crossject Business Overview
7.5.3 Crossject Implantable and Needle-Free Drug Delivery Major Product Offerings
7.5.4 Crossject Implantable and Needle-Free Drug Delivery Revenue in Global Market (2017-2022)
7.5.5 Crossject Key News
7.6 BD
7.6.1 BD Corporate Summary
7.6.2 BD Business Overview
7.6.3 BD Implantable and Needle-Free Drug Delivery Major Product Offerings
7.6.4 BD Implantable and Needle-Free Drug Delivery Revenue in Global Market (2017-2022)
7.6.5 BD Key News
7.7 Mystic Pharmaceuticals
7.7.1 Mystic Pharmaceuticals Corporate Summary
7.7.2 Mystic Pharmaceuticals Business Overview
7.7.3 Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Major Product Offerings
7.7.4 Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Revenue in Global Market (2017-2022)
7.7.5 Mystic Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Implantable and Needle-Free Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Implantable and Needle-Free Drug Delivery Market Drivers in Global Market
Table 3. Implantable and Needle-Free Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Implantable and Needle-Free Drug Delivery in Global Market
Table 5. Top Implantable and Needle-Free Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Implantable and Needle-Free Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Implantable and Needle-Free Drug Delivery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Implantable and Needle-Free Drug Delivery Product Type
Table 9. List of Global Tier 1 Implantable and Needle-Free Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Implantable and Needle-Free Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Implantable and Needle-Free Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Implantable and Needle-Free Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Implantable and Needle-Free Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Implantable and Needle-Free Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 30. Boston Scientific Corporate Summary
Table 31. Boston Scientific Implantable and Needle-Free Drug Delivery Product Offerings
Table 32. Boston Scientific Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Implantable and Needle-Free Drug Delivery Product Offerings
Table 35. Bayer Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 36. Medtronic Corporate Summary
Table 37. Medtronic Implantable and Needle-Free Drug Delivery Product Offerings
Table 38. Medtronic Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 39. Pharmajet Corporate Summary
Table 40. Pharmajet Implantable and Needle-Free Drug Delivery Product Offerings
Table 41. Pharmajet Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 42. Crossject Corporate Summary
Table 43. Crossject Implantable and Needle-Free Drug Delivery Product Offerings
Table 44. Crossject Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 45. BD Corporate Summary
Table 46. BD Implantable and Needle-Free Drug Delivery Product Offerings
Table 47. BD Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 48. Mystic Pharmaceuticals Corporate Summary
Table 49. Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Product Offerings
Table 50. Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Implantable and Needle-Free Drug Delivery Segment by Type in 2021
Figure 2. Implantable and Needle-Free Drug Delivery Segment by Application in 2021
Figure 3. Global Implantable and Needle-Free Drug Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Implantable and Needle-Free Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Implantable and Needle-Free Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Implantable and Needle-Free Drug Delivery Revenue in 2021
Figure 8. By Type - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
Figure 12. US Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
Figure 16. Germany Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 17. France Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
Figure 24. China Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. India Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
Figure 30. Brazil Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Implantable and Needle-Free Drug Delivery Revenue Market Share, 2017-2028
Figure 33. Turkey Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. Boston Scientific Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Medtronic Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pharmajet Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Crossject Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BD Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
